COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION. Name Birthdate / /

Similar documents
SUBOXONE FILM NEW PATIENT INTRODUCTION

Patient Agreement for the use of Opioid Medications

PATIENT INTAKE: MEDICAL HISTORY. Name. Address. Phone (W) (H) (C) DOB Age SS# Emergency Contact. Relationship to patient Phone

Ahsan U. Rashid, M.D., F.A.C.P.

Controlled Substance and Wellness Agreement

For female patients only: To the best of my knowledgei am NOT pregnant. Patients Initials:

PATIENT HISTORY DATA FORM Psychiatric, Health and Wellness, LLC 810 Michael Drive, Suite L Chesterton, IN NAME

Prepublication Requirements

Applicant s Name (PRINT): Applicant s Signature: Date: Anticipated Admission Date: Time: Staff Approval: Date:

Patient Information Form

SUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets. Risk Evaluation and Mitigation Strategy (REMS) Program

OPIOID PAIN MEDICATION Agreement and Informed Consent

INFORMED CONSENT FOR OPIOID TREATMENT FOR NON-CANCER/CANCER PAIN Texas Pain and Regenerative Medicine

WELCOME TO OUR PRACTICE

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

MEDICATION MANAGEMENT AGREEMENT

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine

New Patient Information

PATIENT SIGNATURE: DOB: Date:

Access Endodontics Marat Tselnik, DDS -PRACTICE LIMITED TO ENDODONTICS-

Buprenorphine & Controlled Substance Treatment Agreement

Wilson C, Fagan E. Providing office-based treatment of opioid use disorder. Ann Fam Med. 2017;15(5):481.

APPLICATION FOR ADMISSION (PLEASE PRINT CLEARLY)

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

MEDICATION ASSISTED TREATMENT

Tuscarawas County Health Department. Vivitrol Treatment Consent

Updated: 08/2017 DMMA Approved: 11/2017

Methadone Treatment. in federal prison

Addiction is overwhelming. Recovery doesn t have to be.

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

Appendix F Federation of State Medical Boards

Methadone Treatment. in federal prison

New Client Reformer Session Packet

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

Substance Abuse Level of Care Criteria

Medication-Assisted Treatment. What Is It and Why Do We Use It?

MEDICATION MANAGEMENT AGREEMENT Pain Management Program Participation Agreement and Consent

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

Vivitrol Drug Court and Medication Assisted Treatment

The CARA & Buprenorphine Prescribing for APNs & PAs

APPLICATION FOR SERVICES

PATIENT TREATMENT CONTRACT

ANSWER: There are 18 medicine drop box locations in Lehigh County and 23 medicine drop box locations in Northampton County.

Talking with your doctor

California. Prescribing and Dispensing Profile. Research current through November 2015.

Top of the World Ranch Treatment Centre Admissions Information Record Demographics

Patient and Family Agreement on Opioids

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015.

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

Methadone Maintenance 101

David Palmieri, D.M.D., M.S., LTD., Frank R. Portell D.M.D.,M.S. & Nathan Schoenly, D.D.S. Please Check: Mr. Ms. Mrs. Dr. Fr. Sr. Hon.

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)

*IN10 BIOPSYCHOSOCIAL ASSESSMENT*

Top of the World Ranch Treatment Centre Admissions Information Record Demographics

Prescription Drug Safety for Teens

Fighting Today s Opioid Epidemic

Methadone/ Suboxone Treatment in federal prison

Program Application. Name: SSN: Address: City: State: Zip: Phone: Date of Birth: Age: Occupation: Highest Grade Completed/College/Degree:

Effective Date: May 19, Revised Date: August 18, Policy Number: MED Policy 313. Pain Management Long Term Opioid Use

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

SUBOXONE TREATMENT PROGRAM

SUBOXONE INSTRUCTIONS FOR INITIAL APPOINTMENT

CONTROLLED SUBSTANCE (NARCOTIC) AGREEMENT

Address (if different from above):

If you do not have health insurance, the initial appointment will be $232. Follow-up appointments will be $104.

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII)

Brief History of Methadone Maintenance Treatment

In 2008, an estimated 282,000 persons

Prescription Monitoring Program (PMP)

Opioid Dependence and Buprenorphine Management

Name: Gender: male female Age: Date of birth: / / Preferred phone: cell home work other. Alternate phone: cell home work other.

Sober Housing Guidelines/Agreement

Understanding Medication in Addiction Treatment for Drug Court Participants

OUTPATIENT SERVICES PSYCHOLOGICAL SERVICES CONTRACT

ADULT INTAKE QUESTIONNAIRE. Ok to leave message? Yes No. Present psychological difficulties please check any that apply to you at this time.

the facts about BUPRENORPHINE for Treatment of Opioid Addiction

Information and Consent for Administration of Immunotherapy (Allergy Injections)

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Transitional House Application

Buprenorphine treatment

201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone.

Opioid dependence and buprenorphine treatment

Personal Training Registration Packet

Suboxone, Zubsolv, Bunavail (buprenorphine with naloxone sublingual tablets and film), Buprenorphine sublingual tablets

Vermont. Prescribing and Dispensing Profile. Research current through November 2015.

Preferred Name (s): Local Address: City: State: Zip: Permanent Address: City: State: Zip: Years of Education: Occupation: Gender: M F

Tracker e-prescribing 101. The Complete Guide

Baby-Sitting - $20 Per Day/Per Nanny (local clients) Less than 24 hours notice $30 Per Day/Per Nanny. Hotel Overnight Sitting - $35 per Day/Per Nanny

The science of the mind: investigating mental health Treating addiction

Clinical Guidelines for the Pharmacologic Treatment of Opioid Use Disorder

DRUG COURT PARTICIPANT HANDBOOK NAVAJO COUNTY SUPERIOR COURT HOLBROOK, ARIZONA

FREQUENTLY ASKED QUESTIONS PATIENTS SUBOXONE (buprenorphine HCl/naloxone HCl dihydrate) sublingual tablet

REGISTRATION FORM. PATIENT INFORMATION Información del paciente. Patient s last name (Apellido) : First(Nombre): Middle (Segundo nombre): Mr. Mrs.

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

Lake Psychological Services, LLC

STATE OF NEW JERSEY DEPARTMENT OF CORRECTIONS. Medication Assisted Treatment For Substance Use Disorder In the New Jersey County Jails

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

9/9/2016. Drug Name (select from list of drugs shown) Bunavail Buccal Film (buprenorphinenaloxone) Suboxone Sublingual Film (buprenorphine-naloxone)

Transcription:

COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION Name Birthdate / / Home phone ( ) - Cell phone ( ) - Please answer the following questions which will help us to design your plan of treatment: Why are you interested in our rehabilitation program? Have you been previously treated with Suboxone? yes no When/Where was your last treatment? How long were you treated? Is there any problem that makes it difficult for you to give routine urine specimens? yes no If yes, please explain History: Please list all drugs you have used in the past: Have you ever injected IV drugs? If yes, have you ever shared needles? Have you ever been tested for HIV/AIDS? yes no yes no yes no If yes, what was the date of your last test? Result? Neg Pos Have you ever been tested for Hepatitis B or C? If yes, are you being treated for Hepatitis B or C? yes no yes no Have you ever been treated for substance dependence or misuse (e.g., detoxification program)? yes no If yes, please describe setting, length Have you ever overdosed on alcohol or drugs? yes no Have you ever been treated by a psychiatrist? yes no (Please describe treatment reason, setting, and length) Have you ever been suicidal? yes no Have you ever been homicidal? yes no 1

Current: Please list the drugs you use and when your last use was: Drug: Last used: Drug: Last used: Drug: Last used: Drug: Last used: Are these drugs prescribed, bought on the street, or both? Drinking Pattern: Daily Periodic Binge Weekend only Amount typically consumed (#of drinks)? Type of Alcohol (check all that apply): Beer Wine Liquor Are you currently taking Xanax, Valium, Klonopin, Ambien or any benzodiazepine? yes no If so, which one(s) and how much? Are you willing to taper off of the benzodiazepine listed above? yes no Have you ever had a seizure from alcohol or benzo withdrawal? yes no Are you willing to stop drinking alcohol? yes no Are you willing to stop smoking marijuana? yes no Have you ever had DT s? yes no Do you have any current or past legal issues that have resulted from your addiction? yes no If yes, explain Are you currently employed? yes no How many hours/week (avg.)? What caused you to start using opiates originally? Have you ever tried to quit on your own? yes no Please describe? What are the major sources of stress in your life? 2

What are your major strengths to deal with the stress in your life? What coping methods have you developed to deal with triggers to relapse? What benefit do you expect from Suboxone? Please describe your current living arrangements: Does anyone in your family (mother, father, brother/sister, child, aunt/uncle or grandparent) have a current or past history of substance abuse? yes no If yes, please list who and what substance: Do you have any medical conditions (diabetes, heart disease, hepatitis, HIV+, epilepsy, STDs, etc.)? yes no If yes, please explain Are you currently taking any medications to treat these conditions? yes no (List medication and dosage) Are you pregnant? ( ) N/A ( ) N ( ) Y ( ) Not Sure List ALL of your current physicians: The safety of your Suboxone medication or prescription is your responsibility. Requests for replacement Suboxone will not be honored without an appointment. Do you understand that following the loss or theft of your prescription, it is at the discretion of our physician to determine whether you will be allowed to continue in this program? yes no I have completed this form truthfully and to the best of my ability. Signature Date 3

SUBOXONE NEW PATIENT INTRODUCTION Our clinic restricts our treatment panel to a limited number of pre-qualified patients. This program accepts only patients who are serious about overcoming opiate addiction. We do not assume general medical care of Suboxone patients. ALL patients must adhere to strict cash payment policies. This is a 13-month recovery program. To register please complete: STEP ONE Read the entire packet. Return completed forms to our office. You will be contacted by phone before acceptance. STEP TWO If accepted, our office will call to schedule your first appointment. Schedule first 3 appointments with prepayment of $350 by cash or credit card. STEP THREE Arrive IN WITHDRAWAL for first appointment of up to 3 hours. Be prepared for a urine drug screen. You will receive your prescription and you will be directed to the pharmacy to fill the prescription. Return with filled prescription to continue the initial visit. STEP FOUR Return for two follow up visits, the first 2-3 days after initial visit and the second 7-10 days after initial visit (included in the prepayment made in STEP TWO) At you 3 rd appointment, schedule a two-week follow up with prepayment of $85 cash or credit card Plan to schedule monthly maintenance visits thereafter. o Work/ school notes will be given as appropriate. Plan to attend 1 session of in-office mandatory Group Therapy and 2 AA meetings monthly. Duration of the treatment is individually determined by the patient, but will not exceed 13 months. If a visit is missed with no warning, if you are found to be using, or fail a urine drug screen, return to STEP ONE. You will be given a prescription for a 2-week taper dose, and you will be required to apply for re-acceptance into the program. Re-acceptance is not guaranteed. Prior missed appointment fee ($150) must be paid before reacceptance. 4

SUBOXONE PATIENT RESPONSIBILITIES I agree to store medication properly. Medication may be harmful to children, household members, guests, and pets. The pills should be stored in a safe place, out of the reach of children. If anyone besides the patients ingests the medication, the patient must call the Poison Control Center or 911 immediately. I agree to take the medication only as prescribed. The indicated dose should be taken daily, and the patient must not adjust the dose on his/her own. I agree to comply with the required pill counts and urine tests. Urine testing is a mandatory part of office maintenance; therefore, the patient must be prepared to give a urine sample for testing at each clinic visit. The patient should bring his or her medication to each appointment and may be asked to show the medication bottle for a pill count, including reserve medication. Patient may be asked to come in for random urine drug screens and/or pill counts and must comply within 24 hours of receiving notice. I agree to make and prepay for another appointment in case of a lost or stolen medication. I agree to notify the clinic in case of relapse to drug abuse. Relapse to opiate drug abuse can result in being removed from the Suboxone program. An appropriate treatment plan must be developed as soon as possible. The physician should be informed of a relapse before random urine testing reveals it. I agree to the guidelines of office operations. I understand the procedure for making appointments and paying for missed appointments and late cancellation fees. I have the phone number of this clinic and I understand the office hours. I understand that no medications will be prescribed by phone or on weekends. I understand that I am required to abide by these restraints in order to remain on the Suboxone treatment panel of this office. I understand that this treatment program does not provide medical or surgical care outside the scope of routine Suboxone maintenance. Signature Date 5

SUBOXONE TREATMENT FINANCIAL POLICIES Fees: $350- Includes Initial Three Visits and 12-Step Program Materials $85- Monthly Medication Management and Individual Counseling $25- MANDATORY Group Meetings once monthly Prepayment is required for all visits. We accept credit card, debit card, money order, or cash. NO CHECKS. The cost for the initial evaluation and Suboxone induction treatment is $350. This includes 3 visits (the initial visit along with 2 additional within 2-7 days). Additionally, direct access to private therapy, family therapy, a life coach, yoga, and meditation are provided for a small program fee. These services are provided to aid you in your recovery. There is a $150 cancellation fee (less than 24 hours notice) for the first visit. The cost for follow up appointments is $85. Follow up appointments are scheduled every 2-4 weeks. Urine drug screening may be done as frequently as every visit. The cost of drug screening in our office is $55 for a full panel or $15 for a Suboxone-only panel. Payment for all prior visits must remain current in order to retain your reservation on the panel. We do not wish you to undergo sudden withdrawal from Suboxone. This will be the result if you fail to reserve and keep your appointments. There is an $85 cancellation fee (less than 24 hours notice) for follow up appointments. Your reservation in our limited program is secured with a paid up account. At the conclusion of your visit you will be asked to reserve your next visit. You may be required to go to the medical lab at the end of the first office visit for blood and urine samples, metabolic profiles, HIV, and drug screening. Additional tests may be required as indicated by history and examination. Payment will be expected at the time of service. Future charges for lab tests may be billable by the lab to the patient. Please fill in your credit card information below. This information will be used by our office for the first visit payment and future payments after your acceptance. Credit Card Information Type: MasterCard Visa Discover Credit Card No.: Expiration Date: / Security Code: (3 or 4 digit # on card) Signature: Print Name: (Your signature authorizes Compass Recovery to process your credit card for any charges incurred.) 6

SUBOXONE TREATMENT INFORMED CONSENT Suboxone (buprenorphine + naloxone) is an FDA approved medication for treatment of opiate (narcotic) dependence. It can be used for detoxification or for maintenance therapy. It can cause withdrawal reactions from standard narcotics or Methadone while at the same time having a mild narcotic pain relieving effect from the Suboxone. The use of Suboxone can result in physical dependence of the buprenorphine, but withdrawal is much milder and slower than with heroin or Methadone. If Suboxone is suddenly discontinued, patients will have only mild symptoms such as muscle aches, stomach cramps, or diarrhea lasting several days. To minimize the possibility of opiate withdrawal, Suboxone may be discontinued gradually, usually over several weeks or more. Because of its narcotic-reversing effect, if you are dependent on opiates, you should be in as much withdrawal as possible when you take the first dose of Suboxone. You must be off Methadone for at least 24 hours (after tapering yourself down to at least 40mg per day) or off of other narcotics for at least 12 hours and showing signs of withdrawal before starting Suboxone. Some patients find that it takes several days for the transition to Suboxone from the opiate they had been using. After stabilized on Suboxone, other opiates will have virtually no effect. Attempts at more opiates could result in an opiate overdose. Do not take any other medication without discussing it with your physician. Combining Suboxone with alcohol or some other medications may also be hazardous. We do not prescribe, under any circumstances, narcotics, Methadone, or sedatives for patients desiring maintenance or detoxification from narcotics. All Suboxone must be purchased at pharmacies. We will not supply any Suboxone. Signature Date 7

SUBOXONE TREATMENT FOLLOW UP APPOINTMENTS Follow up appointments will be at least monthly. The visits are focused on evaluating compliance and the possibility of relapse. They may include: Film/Pill counts Urine testing for drug abuse An interim history of any new medical problems or social stressors 12 Step Program discussion Prescription of medication No refills of Suboxone will be made for any reason except during a clinic visit. Appointments do not include evaluation or care for other problems Dangerous behavior, relapse and relapse prevention. The following behavior red flags will be addressed with the patient as soon as they are noticed: Missing appointments Running out of medication too soon Taking medication off schedule Refusing urine testing Neglecting to mention new medication or outside treatment Agitated behavior Frequent or urgent inappropriate phone calls Outbursts of anger Lost or stolen medication Non-payment of visits as agreed, missed appointments or cancellations within 24 hours of your appointment Treatment may be discontinued if these behaviors occur SUBOXONE TREATMENT MAINTENANCE Suboxone treatment may be discontinued for several reasons: If you are unable to stop your dependence, or if you continue to feel like using narcotics, even at the top doses of Suboxone, the doctor will discontinue treatment with Suboxone and you will be required to seek help elsewhere. If you do not abide by our agreements you may be discharged from the Suboxone treatment program. Prompt payment of clinic fees is part of this program. If your account does not remain current, appointments cannot be scheduled. If appointments cannot be kept as agreed, your status as an active patient will be cancelled. In the case of an allergic reaction to medication, Suboxone must be discontinued. Dangerous or inappropriate behavior will result in your discharge from the Suboxone treatment. o In the case of dangerous behavior there will be no two-week taper. You will be discharged and asked not to return. Not attending mandatory group and/or mandatory 2 AA meetings. 8

THERAPY REQUIREMENTS Group therapy will be held in the lobby of Prince Ave Primary Care from 6:30-7:30 every Tuesday and Wednesday. You will be required to attend at least 1 group therapy session each month. You will sign up at your monthly appointment. Group therapy will include 12 Step Principles, and learning other life skills and coping mechanisms to aid in your recovery. Through the process of sharing your recovery and abstinence, you will strengthen your pursuit of recovery. Group success depends on consistent attendance and dedication from every individual. This should be a place of compassion of surrender. You will be required to attend at least 2 AA meetings monthly and obtain the signature of the meetings leader. CERTIFICATES The sixth month and the twelfth month of sobriety Dr. Gibson will award you with a certificate of congratulations. This reward process is important so that you are able to recognize your significant growth. 9

SUBOXONE MATERIALS CONFIRMATION INITIAL BELOW: Questionnaire New Patient Introduction Patient Responsibilities Financial Policy Follow Up Protocols Maintenance Informed Consent Therapy Certificates My signature below and initials by the name of each individually listed document, certifies that I fully understand and agree to the contents of each document. Signature Printed name Date FOR OFFICE USE ONLY INITIAL VISIT DATE: SECOND VISIT DATE: THIRD VISIT DATE: ADDITIONAL VISIT DATES: URINE DRUG SCREEN DATES: GROUP THERAPY MEETING DATES: AA MEETING DATES: 10